EP2421533
Nýir bólgueyðandi miðlar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
21.4.2010EP published:
17.10.2018EP application number:
10714825.6
EP translation filed:
19.11.2018Grant published:
15.12.2018EPO information:
European Patent Register
Max expiry date:
20.4.2030Expiry date:
20.4.2023
Title:
NOVEL ANTI-INFLAMMATORY AGENTS
Timeline
Today
21.4.2010EP application
17.10.2018EP Publication
19.11.2018Translation submitted
15.12.2018Registration published
20.4.2023Expires
Owner
Name:
Resverlogix Corp.Address:
300, 4820 Richard Road SW, Calgary, AB T3E 6L1, CA
Inventor
Name:
HANSEN, Henrik, C.Address:
CalgaryAB T2L 1E6, CA
Name:
WAGNER, Gregory, S.Address:
Foster CityCA, US
Name:
ATTWELL, Sarah, C.Address:
CalgaryAB T3B 2K5, CA
Name:
MCLURE, Kevin, G.Address:
CalgaryAB T2W 4V4, CA
Name:
KULIKOWSKI, Ewelina, B.Address:
CalgaryAB T3H 4N9, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
171620 PDate:
22.4.2009Country:
US
Classification
Categories:
A61K 31/47, C07D 239/91
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 8.3.2019
Expires: 20.4.2020
Payer: Árnason Faktor
Number: 11
Paid: 10.3.2020
Expires: 20.4.2021
Payer: Árnason Faktor ehf.
Number: 12
Paid: 10.3.2021
Expires: 20.4.2022
Payer: Árnason Faktor ehf.
Number: 13
Paid: 10.3.2022
Expires: 20.4.2023
Payer: Árnason Faktor ehf.